Flowserve Corporation reports Q2 results on July 30 with shorts unwinding sharply and options positioning at some of the most call-heavy levels of the past year — a setup that contrasts with a Street still cautious on top-line growth.
The most striking shift in positioning is the short interest collapse over the past month. Shorts are in clear retreat: SI has fallen from roughly 10.4% of the free float in late June to 7.1% now — an 18% drop in shares short over thirty days. The bulk of that cover came in July, with the position shrinking almost every session since July 9. That unwind coincides with the stock's 8.8% gain on the week to $73.43, suggesting covering has contributed meaningfully to the move. Borrow conditions remain relaxed — availability is running near 587%, well above even the 52-week low of 219%, meaning the lending market poses no obstacle to new short positions if sentiment reverses. Cost to borrow is just 0.66%, up about 11% on the week but still comfortably low. The borrow market tells a story of shrinking short conviction, not a squeeze in progress.
Options traders amplify that picture. The put/call ratio has dropped to 0.14, nearly 1.4 standard deviations below its 20-day average of 0.18 — close to the 52-week low of 0.11. That's an unusually call-heavy setup, reflecting demand for upside exposure rather than hedging ahead of the print. The PCR has drifted lower consistently since mid-July, tracking the short cover with a consistent directional lean. Together, the two signals suggest the market is positioned for a positive outcome — not cautiously, but with some conviction.
The Street is more split. Six analysts carry buy ratings against four holds, with a consensus mean target of $88.50 — implying roughly 20% upside from current levels. But recent moves have been mixed and mostly skew lower on targets. TD Cowen downgraded to Hold in late June, cutting the target from $85 to $70 — a notable move from a bellwether industrial franchise name. Earlier in the cycle, RBC and Jefferies both trimmed targets while keeping positive ratings. The bull case centres on the impressive margin expansion — 370 basis points of adjusted operating margin improvement to 14.8%, driven by North America and Middle East demand alongside nuclear and power bookings momentum. The bear case is simpler: management already cut organic sales guidance to 1-3%, and the stock's valuation at roughly 16.8x earnings leaves limited room for disappointment. The EV/EBITDA multiple is running near 11.3x, up modestly on the week but still below the level that would imply full pricing-in of the margin story.
Past earnings reactions add relevant texture heading into tomorrow. The May 14 print produced a 2.1% one-day decline but recovered to a 3.4% gain over five sessions — a modest sell-the-news reaction that found buyers. The April 30 event was more severe: a 15% one-day drop that did not recover in the following week. Two data points don't make a pattern, but they do flag that Flowserve has delivered wide outcomes on results days in 2026. The ORTEX short score of 49.1 — roughly mid-range and drifting slightly lower over the past two weeks — is consistent with shorts receding rather than building fresh pressure.
What to watch after the July 30 print: whether management revises organic sales guidance above the current 1-3% range, and how the options market responds given the current call-heavy setup is priced for an upside surprise.
See the live data behind this article on ORTEX.
Open FLS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
